MedPath
HSA Approval

METHYCOBAL TABLET 500 mcg

SIN06291P

METHYCOBAL TABLET 500 mcg

METHYCOBAL TABLET 500 mcg

June 20, 1991

EISAI (SINGAPORE) PTE. LTD.

EISAI (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEISAI (SINGAPORE) PTE. LTD.
Licence HolderEISAI (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, SUGAR COATED

**Dosage and Administration** The usual daily dose for adults is 3 tablets, equivalent to a total of 1,500 mcg of mecobalamin, administered orally in 3 divided doses. The dose may be adjusted according to the age of patient and severity of symptoms.

ORAL

Medical Information

**Indications** Peripheral neuropathies

B03BA05

mecobalamin

Manufacturer Information

EISAI (SINGAPORE) PTE. LTD.

BUSHU PHARMACEUTICALS LTD.

Active Ingredients

MECOBALAMIN

500 mcg

Mecobalamin

Documents

Package Inserts

Methycobal Approved PI - 100T.pdf

Approved: September 1, 2016

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METHYCOBAL TABLET 500 mcg - HSA Approval | MedPath